Adan Rios Sigmund H Hsu Angel Blanco Jamie Buryanek Arthur L Day Mary F McGuire Robert E Brown
10.18632/oncoscience.311
Oncoscience
2016 Jun 11;3(5-6):156-63.
biomedical analytics glioblastoma morphoproteomics plerixafor preventative and targeted therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/27489862/
Case Reports
PMC4965258
27489862
Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and niacinamide
2016